Grace Collord

Grace Collord

Auto-generated profile, based on publicly available information

Grace Collord

Wellcome Sanger Institute, Hinxton, UK

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2018 in Nature
Verified
Journal Article
Open access
PDF file
SASagi Abelson
Sagi Abelson
GCGrace Collord
Grace Collord
SNStanley W. K. Ng
Stanley W. K. Ng
OWOmer Weissbrod
Omer Weissbrod
NCNetta Mendelson Cohen
Netta Mendelson Cohen
LSLiran I. Shlush
Liran I. Shlush
The incidence of acute myeloid leukaemia (AML) increases with age and mortality exceeds 90% when diagnosed after age 65. Most cases arise without any detectable early symptoms and patients usually present with the acute complications of bone marrow failure1. The onset of such de novo AML cases is typically preceded by the accumulation of somatic mutations in preleukaemic haematopoietic stem and progenitor cells (HSPCs) that undergo clonal expansion2,3. However, recurrent AML mutations also accumulate in HSPCs during ageing of healthy individuals who do not develop AML, a phenomenon referred to as age-related clonal haematopoiesis (ARCH)4,5,6,7,8. Here we use deep sequencing to analyse genes that are recurrently mutated in AML to distinguish between individuals who have a high risk of developing AML and those with benign ARCH. We analysed peripheral blood cells from 95 individuals that were obtained on average 6.3 years before AML diagnosis (pre-AML group), together with 414 unselected age- and gender-matched individuals (control group). Pre-AML cases were distinct from controls and had more mutations per sample, higher variant allele frequencies, indicating greater clonal expansion, and showed enrichment of mutations in specific genes. Genetic parameters were used to derive a model that accurately predicted AML-free survival; this model was validated in an independent cohort of 29 pre-AML cases and 262 controls. Because AML is rare, we also developed an AML predictive model using a large electronic health record database that identified individuals at greater risk. Collectively our findings provide proof-of-concept that it is possible to discriminate ARCH from pre-AML many years before malignant transformation. This could in future enable earlier detection and monitoring, and may help to inform intervention.

10 August 2018 in Science
Verified
Journal Article
Closed access
PDF file
MYMatthew D. Young
Matthew D. Young
TMThomas J. Mitchell
Thomas J. Mitchell
FBFelipe A. Vieira Braga
Felipe A. Vieira Braga
MTMaxine G. B. Tran
Maxine G. B. Tran
BSBenjamin J. Stewart
Benjamin J. Stewart
SBSam Behjati
Sam Behjati
Pediatric and adult kidney tumors differ: Understanding tumor origins and the similarities and differences between organ-specific cancers is important for determining treatment options. Young et al. generated more than 72,000 single-cell transcriptomes from healthy and cancerous human kidneys. From these data, they determined that Wilms tumor, a pediatric kidney cancer, originates from aberrant fetal cells, whereas adult kidney cancers are likely derived from a specific subtype of proximal convoluted tubular cell. Science , this issue p. 594

27 September 2019 in Science
Verified
Journal Article
Closed access
PDF file
BSBenjamin J. Stewart
Benjamin J. Stewart
JFJohn R. Ferdinand
John R. Ferdinand
MYMatthew D. Young
Matthew D. Young
TMThomas J. Mitchell
Thomas J. Mitchell
KLKevin W. Loudon
Kevin W. Loudon
MCMenna R. Clatworthy
Menna R. Clatworthy
Immune landscape of the human kidney: Single-cell RNA sequencing has begun to shed light on the full cellular diversity of specific organs. However, these studies rarely examine organ-specific immune cells. Stewart et al. sequenced healthy adult and fetal kidney samples at a single-cell level to define the heterogeneity in epithelial, myeloid, and lymphoid cells. From this dataset, they identified zonation of cells, with relevance to disease and the varied perturbations that occur in different tumor settings. This profiling of the human kidney generates a comprehensive census of existing cell populations that will help inform the diagnosis and treatment of kidney-related diseases. Science , this issue p. 1461

23 June 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
SBSam Behjati
Sam Behjati
PTPatrick S. Tarpey
Patrick S. Tarpey
KHKerstin Haase
Kerstin Haase
HYHongtao Ye
Hongtao Ye
MYMatthew D. Young
Matthew D. Young
PCPeter J. Campbell
Peter J. Campbell
Osteosarcoma is a primary malignancy of bone that affects children and adults. Here, we present the largest sequencing study of osteosarcoma to date, comprising 112 childhood and adult tumours encompassing all major histological subtypes. A key finding of our study is the identification of mutations in insulin-like growth factor (IGF) signalling genes in 8/112 (7%) of cases. We validate this observation using fluorescence in situ hybridization (FISH) in an additional 87 osteosarcomas, with IGF1 receptor (IGF1R) amplification observed in 14% of tumours. These findings may inform patient selection in future trials of IGF1R inhibitors in osteosarcoma. Analysing patterns of mutation, we identify distinct rearrangement profiles including a process characterized by chromothripsis and amplification. This process operates recurrently at discrete genomic regions and generates driver mutations. It may represent an age-independent mutational mechanism that contributes to the development of osteosarcoma in children and adults alike.

7 May 2018 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
MGMalgorzata Gozdecka
Malgorzata Gozdecka
EMEshwar Meduri
Eshwar Meduri
MMMilena Mazan
Milena Mazan
KTKonstantinos Tzelepis
Konstantinos Tzelepis
MDMonika Dudek
Monika Dudek
BHBrian J. P. Huntly
Brian J. P. Huntly

6 December 2019 in Science
Verified
Journal Article
Closed access
PDF file
TCTim H. H. Coorens
Tim H. H. Coorens
TTTaryn D. Treger
Taryn D. Treger
RAReem Al-Saadi
Reem Al-Saadi
LMLuiza Moore
Luiza Moore
MTMaxine G. B. Tran
Maxine G. B. Tran
SBSam Behjati
Sam Behjati
A childhood tumor—from the beginning: Many adult cancers arise from clonal expansions of mutant cells in normal tissue. These premalignant expansions are defined by somatic mutations shared by the cancers. Whether pediatric cancers originate in a similar way is unknown. Coorens et al. studied Wilms tumor, a childhood kidney cancer. Phylogenetic analyses revealed large clones of mutant cells in histologically and functionally normal kidney tissue long before tumor development. Thus, like adult tumors, Wilms tumor appears to arise from a premalignant tissue bed. Science , this issue p. 1247